Belgian biotech Confo Therapeutics has landed $183 million, plus potential royalties, in a drug-discovery deal with Daiichi Sankyo. Early Thursday, Confo Therapeutics put out word of the deal that will be focused on small molecule […]
RAHWAY, N.J.–(BUSINESS WIRE)—- $MRK #MRK–Merck to Hold First-Quarter 2023 Sales and Earnings Conference Call on April 27 Click here to view original post
CHICAGO–(BUSINESS WIRE)– #GvokeHypoPen–Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapeutic areas, today announced that it has entered […]
The Broad Institute of MIT and Harvard, in collaboration with UCLA, and the New York Genome Center to create the BD² Genetics Platform The CommonMind Consortium (Icahn School of Medicine at Mount Sinai, University of […]
The bulk of the donation will be used to establish three endowed positions at Thomas Jefferson University. Click here to view original post
Dr. Christopher Olivia was brought in two years ago to run the 1,800-person Rothman Orthopaedic Institute, the region’s largest orthopedic group. Click here to view original post
It’s the latest growth of the UPMC Health Plan unit since it widened past Pennsylvania in 2018. Click here to view original post
Despite a very satisfied Vabysmo user-base, Regeneron’s 8mg aflibercept is already highly anticipated by ophthalmologists and likely to throw a wrench into Vabysmo’s positive trajectory. EXTON, Pa., March 29, 2023 /PRNewswire/ — According to Spherix […]
Paul McKenzie took over as CEO of Australian pharma giant CSL this month, following in the footsteps of long-time CSL vet Paul Perreault. With an eye on mRNA, and quickly commercializing its new, $3.5 million-per-shot gene […]
Boehringer Ingelheim reported human pharma sales of €18.5 billion on Wednesday, led by type 2 diabetes and heart failure drug Jardiance and pulmonary fibrosis med Ofev. Jardiance sales reached €5.8 billion, growing 39% year over […]
Copyright © 2023 Biotech Networks, LLC
